Please assess the completion status of the following clinical trial:

Trial Title: Amlodipine 10mg Drug Use Investigation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects who have been treated with amlodipine 5mg at least 4 weeks~* The subjects who had not achieved target BP~Exclusion Criteria:~* Subjects who have been prescribed amlodipine (Norvasc®) 10mg Tablet before

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Amlodipine 10mg Tablet (Type: None): Subjects taking Amlodipine 10mg Tablet.

Based on this trial design, predict the completion outcome and termination type (if applicable).